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INTRODUCTION
Stone disease causes enormous social and economic burden to the society. The 
lifetime prevalence of kidney stone disease is 1-15% with the probability of having a 
stone  varying according to  age,  gender,  race,  and geographic  location.  Management 
options for renal calculi has changed dramatically during the past 30 years. 
Minimally invasive techniques, especially the introduction and development of 
Extra Corporeal Shock Wave Lithotripsy (ESWL) has virtually replaced open surgical 
stone removal. ESWL was introduced by Christian Chaussay in 1980. Around 80-85% 
of simple renal calculi can be treated effectively with ESWL. 
ESWL is a non invasive therapy for urinary calculi with good success rates and 
decreased morbidity, length of hospitalization and anaesthesia  requirement. According 
to the AUA guidelines, ESWL is the preferred modality of treatment for renal stones  of 
2cm  size.
Even  large  and  complex  renal  calculi  can  be  treated  effectively  with  these 
minimally invasive techniques. For complete staghorn calculi  a combined PCNL and 
ESWL (Sandwich) therapy has been recommended as the first line of treatment.
 However, even for the calculi of this size, the stone free rates vary between 66% - 
99%. This variation in stone fragmentation is due to factors like stone size, location, 
chemical  composition,  BMI,  other  congenital  anatomical  anomalies,  shock  wave 
generator and presence of obstruction (or) infection.
The renal calyces are the most common location of asymptomatic (or) incidentally 
discovered urinary calculi. Pelvic calculi, upper calyceal and middle calyceal stones of 
less than 2cm have been treated with ESWL with stone free rate of upto 99%. 
The  management  of  lower  calyceal  stone  is  more  controversial  and  in  this 
situation, stone free rate after ESWL range from 44-79%. Lower calyceal Stone with 
favourable infundibulo pelvic anatomy have good success rate with ESWL.
Stone fragmentation by ESWL is variable. So it is desirable to reduce the number 
of retreatment (or) limit one definite therapy. In addition to the local effects of ESWL 
upon renal parenchyma, injury to surrounding organs are also of concern. The long term 
prevalence  rate  of  HT and change in  renal  plasma flow following ESWL treatment 
constitute  a further  reason for  the surgeon to limit  the therapy to one stage definite 
treatment. The success of ESWL has been correlated with the radiodensity of the renal 
stone on plain       X-ray KUB.  Overall accuracy of predicting calculi composition from 
plain  radiographs  was  reported  to  be  only  39%, which  is  at  present  insufficient  for 
clinical use.
The Emergence of Non Contrast CT KUB in the assessment of flank pain and the 
subsequent availability of the attenuation coefficient measurement has resulted in many 
studies comparing the attenuation value and stone composition invitro.  These studies 
have determined that stone compositions can be predicted on the basis of the attenuation 
value determined by NCCT.
The density of stone measured by NCCT Hounsfield Unit (HU) varies with stone 
composition and determines the fragility of a calculus which ultimately determines the 
clinical outcome in ESWL. NCCT because of its easy availability, superb sensitivity and 
very high resolution capability, is a good modality for the measurement of stone density.
REVIEW  OF  LITERATURE
The prevalence of stone disease is very high in most parts of India because of its 
geography,  dietary  habits,  temperature  and humidity  superimposed  on their  intrinsic 
factors predisposing to stone formation.  Prevalence of stone disease is 1-15% and varies 
by age, sex and race. For men, incidence begins to rise after age 20, peaks between 40 
and 60 years at about 3/1000/y and then begin to decline. For women incidence rates 
seem to be higher in late 20s (2.5/1000/y) and then decreasing to 1/1000/y age 50. The 
incidence and prevalence of stone disease is increasing in recent years,  may be  due to 
increased detection of asymptomatic stones discovered with the greater use and higher 
sensitivity of imaging studies.
Stone disease can be easily diagnosed using imaging studies like         X-ray KUB, 
USG KUB and CT KUB. Plain radiography detects radio opaque calculi. The limitations 
are bowel gas, bone shadow overlapping the stones, and radiolucent stones.
USG KUB can detect  calculi  in the renal  area and associated obstruction and 
dilatation  of  pelvi  calyceal  system.  Limitations  are  obesity,  bowel  gas  and  poor 
sensitivity for ureteric calculi.
Non contrast CT KUB is a simple method to detect renal and ureteric calculi, 
stone burden with density and dilatation of pelvicalyceal system.
Various  treatment  options  including  non  invasive  modalities  and   minimally 
invasive  surgeries  have  replaced the  open  stone  surgery  nowadays.  Extra  Corporeal 
Shockwave Lithotripsy  is a non invasive treatment option with minimal morbidity. 
The  word lithotriptor is Greek origin and means stone crusher. Lithotriptors have 
evolved from many years of research into the physics of flight. Researchers discovered 
that raindrops striking an air craft during supersonic flight created shockwaves that had 
disintegrating  effects  on  solid  materials.  Refinements  of  these  findings  led  to  the 
intervention of the lithotriptor as a means for treating urinary calculi.
In  February  1980  Dr.  Christian  Chaussay, University  of  Munich  first  used 
electrically generated focused shockwaves to fragment stones within a human kidney. 
The first  Lithotriptor model HM 1 soon replaced by HM 2 in 1982 and in 1984 by 
Model HM 3. Each new generation reflects progression of technology and a growing 
sophistication.  Further  modification  of  the  generation  is  the  consolidation  of 
fluoroscopic  screens and the lithotripsy  control  into a  convenient,  efficient  and user 
friendly console. Shockwave lithotripsy technology has advanced rapidly in terms of 
shock wave generation, focusing, patient coupling and stone localization making it the 
most widely used treatment for renal calculi.
METHODS OF SHOCK WAVE GENERATION
Lithotriptors,  are  characterized  by  the  types  of  shockwave  generators  they 
employ.  Commercially  available  lithotriptors  use  Electrohydraulic  (EH), 
Electromagnetic (EM) and  Piozoelectric generators .
ELECTRO HYDRAULIC (SPARK GAP) GENERATORS
A  spherically  expanding  shockwave  is  generated  by  an  underwater  spark 
discharge (15000-25000V) Electrode at F1 and focused by hemi ellipsoid reflector on to 
the calculus at F2. The advantage of this generator is its effectiveness in breaking kidney 
stones. Disadvantages are substantial pressure fluctuations from shock to shock and  a 
relatively short electrode life. 
ELECTROMAGNETIC GENERATORS
EMSE - Electromagnetic shock wave Emitter. This consists of a disk coil that is 
charged with high voltage pulses (5000-20000V), whereby, the membrane lying directly 
on the coil is thrust outwards. The shock wave generated is focused by means of an 
acoustic lens on the stone.
The advantage of electromagnetic generator is that, it  is more controllable and 
reproducible. Introduction of energy into patients body over a large skin area causes less 
pain. The small focus with high energy densities increases its effectiveness is breaking 
stones.  The  disadvantage  is  also  the   small  focal  region of  high  energy,  leading to 
increased rate of          subcapsular hematoma formation.
PIEZOELECTRIC GENERATOR
Piezoelectric energy source uses a spherical array of piezoelectric crystals excited 
by an electric impulse of 2000-6000V. This results in simultaneous sudden expansion 
and shockwave generation. These waves are focused on to the stone. The advantages are 
the focusing accuracy, a long service life, and anaesthesia free treatment.
The major disadvantage is the insufficient power it delivers, hampering its ability 
to effectively break renal stones. 
SHOCKWAVE FOCUSING
Shock wave focusing allows for the concentration of shockwave energy at a focal 
point.  The  focal  area  refers  to  the  volume  within  which  the  shock  waves  are 
concentrated.
SHOCK WAVE COUPLING
Shock waves can be coupled effectively into the body by degassed water which 
has a  matched acoustic impedance to soft  tissues. Current lithotriptors use enclosed 
water cushion with a coupling medium of ultrasound gel, instead of 1000 L water bath. 
Shock wave attenuation through the membrane of water cushion amounts to 20% loss of 
energy.
STONE LOCALIZATION
Stone localization during lithotripsy is accomplished with either fluoroscopy (or) 
ultrosonography.  Fluroscopy provides the urologist with a familiar modality and the 
added benefit of effective ureteral stone localization. Disadvantages are the radiation 
hazard to both the patient, medical staff and the inability to visualise radiolucent calculi. 
Ultrasonography based lithotriptors offer the advantages of stone localization with 
continuous  monitoring  and  effective  identification  of  radiolucent  stones  without 
radiation  exposure.  Disadvantage  of  ultrasonography  is  inability  to  locate  ureteral 
stones. 
PHYSICAL PROPERTIES OF RENAL CALCULI AND TISSUE
Knowledge of acoustic and mechanical properties of renal calculi and tissue is 
important to understand shockwave – stone tissue interaction and the mechanisms of 
stone fragmentation and tissue injury during ESWL Acoustic properties determine the 
characteristics of shock wave propagation inside the stone and tissue materials as well as 
the  wave  transmission  and  reflection,  at  the  stone  tissue  boundary.  Mechanical 
properties dictate the response of the stone and tissue materials to shock wave loadings. 
Acoustic and mechanical properties of renal calculi depend primarily on the composition 
of stone.
COMPOSITION  AND STRUCTURAL FEATURES OF RENAL CALCULI
The constituents of renal calculi are crystalline (95%) and non crystalline matrix 
materials (Protein, Cellular debris and organic materials)
Major crystalline components are calcium oxalate (Monohydrate and dihydrate), 
phosphates  (hydroxyapatite,  carbonate  apatite  struvite),  uric  acid,  urate,  cystine  and 
xanthine. Renal calculi appear in wide range of shapes, sizes, colors and textures. 
ACOUSTIC PROPERTIES OF RENAL CALCULI AND RENAL TISSUE
Acoustic properties are density, wave speed and acoustic impedance. Longitudinal 
wave propagation (compressional) is characterized by parallel movements of material 
particles along the wave path. In transverse (Shear) wave propagation, material particles 
move perpendicular to wave path.
Calcium oxalate monohydrate and cystine stones have higher acoustic impedance. 
Stones with higher acoustic impedance would produce a stronger reflection of the shock 
wave at the anterior surface of stone resulting in less of the shock wave energy being 
transmitted into the stone to cause  fragmentation.
MECHANICAL PROPERTIES OF RENAL CALCULI
Dynamic  elastic  properties  of  renal  calculi  depend  upon  resistance  of  stone 
material to elongation (or) shortening, shear deformation and volume change. Most renal 
calculi are brittle, while cystine stones are ductile (more energy is needed to produce 
fracture) and the most difficult to fragment during SWL.
MECHANISMS OF VARYING STONE FRAGILITY
Stone fragility determines the response of a renal calculus to SWL. It varies  with 
composition,  size and structural features of stone.
It has been reported that stones with homogenous architecture are less fragile than 
stones with heterogenous structure. Elastic module determines the stone’s resistance to 
shock wave induced deformation. Hardness determines a stone’s resistance to cavitation, 
microjet  impact  and  fracture.  Toughness  determines  a  stone’s  resistance  to  spalling 
damage  and  crack  propagation.  COM(Calcium  oxalate  monohydrate)  and  brushite 
stones are less fragile than MAP(Magnesium ammonium phosphates) and CA(Carboxy 
apatite) stones because COM and brushite stones are stiffer, harder and more resistant to 
fracture. 
MECHANISMS OF STONE FRAGMENTATION 
Damage methods are  surface erosion at  the anterior  surface  of  stone,  spalling 
damage at the posterior surface of stone and layer separation at the interface of adjacent 
stone laminar surface.
Shock  Waves  composed  of  positive  compressive  waves  and  negative  tensile 
waves.
Shock waves produce bubbles 100-200  µs size which collapse rapidly near the 
stone surface, producing high speed microjet (770 m/s) that impinge towards the stone 
surface to cause damage.  On the anterior  surface of stone numerous minute pits are 
formed. It is the specific characteristic of cavitation induced surface erosion.
Spalling damage causes the separation of a spherical cap from posterior surface of 
stone.  This  mode  of  stone  damage  can  be  attributed  to  the  reflected  tensile  waves 
generated at the layer interface because of acoustic impedance mismatch between stone 
crystalline structure and surrounding matrix materials. Numerous micro fracture grow 
and propagate to form large crack lines leading to stone disintegration. 
Calculi  maintain  their  form  because  of  innate  comprehensive  forces. 
Fragmentation occurs when tensile strength of a calculus is overcome by opposing force 
created by shockwaves. Stone fragmentation occurs by several mechanisms.
The ultimate goal  of ESWL is to fragment renal and ureteric calculi as effectively 
as possible with minimizing the potential injury to surrounding tissues.
Stone  fragmentation  varies  according  to  stone  composition  cystine  stones  are 
most  ESWL  resistant.  Next  are  Brushite,  and  Calcium  Oxalate  Monohydrate.  Pre 
treatment determination of stone composition and an ability to predict the  probability of 
fragmentation can reduce the number of fruitless shockwaves and reduce the overall cost 
of stone management. 
Different  techniques  have  been  used  to  assist  in  determining  the  chemical 
composition of urinary calculi in vivo.  Such tests include pH, identifying characterizing 
urinary  crystals,  presence  of  urea  splitting  organisms,  bone  densitometry   and 
radiographic studies.
Roentgenography has played a major role in the diagnosis and management of 
calculus disease. Various researchers have attempted to predict the stone composition by 
different methods.
Dretler pioneered the work on stone fragility and the magnitude of response of a 
calculus to stone fragmentation techniques. The author chose 6 calculi with near 100% 
purity. These were photographed on high resolution roentgenographic paper to compare 
the crystal structure and allow appreciation of differences in their structure. Small spalls 
are noted in the calcium oxalate dihydrate COD   stone,  whereas the appearance of 
calcium oxalate monohydrate and brushite stones are more uniformly dense. Struvite 
calculi show alternating lines of dense and less opaque material. Cystine and uric acid 
calculi  have more homogenous structure, without obvious striations. They concluded 
that except of cystine calculi radiologic density correlated well with stone fragility.
In  1996  Dretler  and  Kolt   further  analyzed  radiographic  patterns  of  calcium 
oxalate  dihydrate  and  monohydrate  stones.  Smooth  edge,  denser  than  bone  and 
homogenous  are  characteristics  of  pure  calcium oxalate  monohydrate  stones.  Radial 
striations  and superimposed stippling pattern are  found in  calcium oxalate  dihydrate 
stones.  This  study is  the  first  proof  that  radiographic  morphology can  be  related  to 
ESWL stone free rate.  
Bone et al  demonstrated that a  smooth, denser than bone                 calcium 
oxalate  monohydrate stone,  fragments  less  efficiently  than rough less  dense calcium 
oxalate dihydrate stone.
Plain radiographs have many limitations. For distinct outline of the renal stone it 
should be of more than 1cm size. Moreover the stone may get masked by overlying 
bowel gas and for obvious appearance it should be located in an area away from bony 
structures.
Cohen et al showed that  an accurate diagnosis of stone composition could be 
made by an analysis of crystals in post ESWL urine specimen using scanning Electron 
Microscopy  and   X-ray  energy  dispersive  spectroscopy  (XES).  His  associates  then 
extended  the  use  of  these  techniques  to  include  examination  of  pre  treatment  urine 
specimen, and thereby predicting the response to ESWL success.  The disadvantage of 
this method is that electron microscopic urine examination may not be easily available 
and there is difficulty in predicting the nature of calculi in patients with mixed stones. 
Cher Saw et al studied the ability of stone density on non contrast CT to predict 
the number of shock waves required for fragmentation of stones. The number of shock 
waves required for fragmentation to less than 3mm was taken as the end point. However 
due to technical defect of volume averaging with 3mm collimation the correlation was 
not due to radiological density but rather solely to stone size. They concluded that the 
size  and  not  HU  which  determined  the  number  of  shockwaves  required  for 
fragmentation.
CT Scan is a relatively simple and non invasive technique that is available in most 
medical centres. Radio opaque and radiolucent calculi  can be detected. Several reports 
have  indicated  that  with  the  use  of  modern  instrumentation  uric  acid  and  poorly 
mineralized matrix stones can be identified with certainty.
Hillman and his  associates sought to determine the feasibility of using CT to 
analyse the chemical composition of renal calculi. He concluded that uric acid stone can 
be differentiated clearly from struvite and calcium oxalate calculi.  
(CT number (or) Hounsfield unit is calculated using the formula).
1000 x   µ  tissue  --  µ   water 
µ Water 
µ - absorption coefficient in kilovoltage. This number is named in honor of 
Godfrey Hounsfield the inventor of CT Scanning when HUs are used air has a value of 
– 1000,  water- 0 and dense bone and calcification              > + 1000.
Federle  et  al (30)  evaluated  9  Patients  and  analysed  CT  HU  with  stone 
composition. In this study 1 uric acid stone has an attenuation value between 346-400 
HU, Xanthine stone had a value of 391 HU, cystine stone 586 HU, calcium oxalate 
500-1000 HU.
Kuwahara et al (31) studied the attenuation value of CT of 50 calculi more than 
1cm in diameter to determine its composition. The attenuation of various calculi were 
measured  in  HU in  5mm collimation  in  the  region  of  interest.  Values  obtained  as 
follows.  Mixed  calcium  oxalate  Phosphate  1555+193,  Magnesium  Ammonium 
Phosphate 1285+284, calcium oxalate 1690, Calcium Phosphate 1440, Cystine 757+114. 
Uric  acid  480.  They  concluded  that  attenuation  values  ranging  from  500-1600 
overlapped for various calculi. However uric acid calculi had attenuation value less than 
500  and  oxalate  calculi  >1000.  They  could  not  find  any  correlation  between  the 
attenuation value and the mineral content. 
AIM AND OBJECTIVES
 To study the density of renal stone by Non contrast CT Scan as measured in HU 
and its correlation with susceptibility of fragmentation by ESWL.
MATERIALS AND METHODS
STUDY DESIGN
This is a prospective study conducted in 100 patients of renal stone disease who 
underwent ESWL treatment at  Madras Medical College,  Chennai,  during the period 
January 2008 to January 2009.
INCLUSION CRITERIA
 Patients with renal stones 8mm – 35mm in diameter who have not received any 
previous treatment for the same.
 All stones located in a satisfactory functioning, non obstructed renal unit.
EXCLUSION CRITERIA
 Bleeding diathesis
 Pregnant females
 Uncontrolled infection
 Ureteric calculi
 Distal obstruction
 Congenital Anomalies
 Patients with cardiac pacemaker
 Lower calyceal stone with unfavourable anatomy.
100 patients with renal stones included in the study. In all patients history and physical 
examination  was  done.  Baseline  investigations  included were Complete  haemogram, 
RFT, urine C/S, X-ray KUB, USG KUB and CT KUB.
NCCT Scan was done in 3mm cuts. Stone density in HU was obtained on the 
particular cut in which the stone was seen in the greatest diameter. Mean stone density 
was calculated in some cases. Patients were explained about the study, ESWL procedure 
and informed consent obtained.
ESWL was done as outpatient procedure. Patient datas recorded in the proforma. 
All treatments were done with Dornier Compact Delta II (Electromagnetic Generator) 
Machine. Patients were administered sedation IV Fortwin (20mg), 30 minutes before 
procedure.  In  paediatric  patients  Endotracheal  General  Anaesthesia  was  given  by 
anaesthetist. Topical EMLA cream was used in some patients.
ESWL  MACHINE
Calculus was focused using  fluoroscopy,  USG probe (in radiolucent stones) A 
maximum of 2500 shocks were given in each sitting. Intensity of shockwaves increased 
stepwise. Shocks frequency was 60 / minute.
Stone fragmentation was monitored fluroscopically after every 100 shock waves 
or  continuously  with  USG  probe  and  the  procedure  was  terminated  once  adequate 
fragmentation was observed.
Adequate fragmentation was accepted when following were observed:-
• Increase in stone surface area
• Alteration in configuration
• Irregularity in outline
• Obviously separated fragment
• Decreased over all density
If the stone size is large (> 2.5cm)  Pre procedure 5F DJ stenting was done. 
After each session of treatment patients were observed for 4-6 hours period and 
allowed to go home. Patients were explained about the post treatment hematuria, pain 
and voiding of fragments. 
Analgesics were given and patients advised to take around 5-6 liters of fluid /day. 
All patients were  instructed to pass urine through sieve (coffee filter) and to collect 
stone fragments. This was brought and given to us at the time of review for chemical 
analysis.
POST PROCEDURE FOLLOW UP
Patients were followed up at 2 weeks with X-ray KUB, USG KUB and CT KUB. 
For those patients with residual fragments II sitting ESWL was instituted. Second follow 
up for those patients who undergone II session of ESWL was done at the end of 4 weeks 
with X-ray KUB, USG KUB and CT KUB. Those patients with residual fragments, III 
sitting ESWL was given. After 2 weeks patients were followed up. 
Residual  calculi  by  X-ray  KUB,  USG KUB   and  CT  KUB <4mm clinically 
insignificant residual fragment were considered adequately treated. Residual fragments 
>4mm were considered treatment failures.
The stone fragments brought by the patient were collected, labeled and sent for 
Chemical Composition Analysis,  Biochemistry Department, Madras Medical College. 
(By Chemical dissolution Method stone composition was detected).
STONE FREE GROUP 
PRE ESWL
POST ESWL
STONE  FRAGMENTATION GROUP
PRE  ESWL FLURO FOCUSING
POST ESWL
STONE  FRAGMENTATION GROUP
PRE ESWL
POST  ESWL
STONE WITH RESIDUAL FRAGMENTS (Failure of 
Treatment)
PRE  ESWL
POST ESWL
ESWL MACHINE
RESULTS
This  study  comprised  of  100  patients  who  had  satisfied  the  inclusion  and 
exclusion criteria mentioned earlier and later underwent NCCT KUB for assessment of 
stone density in HU followed by ESWL (Maximum III Sittings 7500 Shock waves)
SEX  DISTRIBUTION
There were 69 Male Patients and 31 Female Patients in the study.
MALE FEMALE
69 31
SEX DISTRIBUTION
69
31
MALE FEMALE
AGE  DISTRIBUTION
The age of the patients ranged from Adults 97 patients (20-60 years) 
Paediatric age group 3 patiens
ADULTS PAED
97 3
AGE  DISTRIBUTION
97%
3%
ADULTS PAEDIATRIC
SYMPTOM DISTRIBUTION
Majority of patients presented with loin pain (80 out of 100 patients)  other symptoms 
were  dysuria,  Hematuria  and UTI.  20  patients   were  asymptomatic  and incidentally 
detected. 
SYMPTOMS NO. OF 
PATIENTS 
PERCENTAGE
Flank Pain 80 80%
Dysuria 10 10%
Fever 5 5%
Asymptomatic Incidentally Detected 20 20%
STONE SIZE DISTRIBUTION
The largest calculus was 35mm and smallest was 8mm.
In our study stone of size 8-15mm in 70 patients (70%) 16-25mm in 17 patients  (17%) 
and 26-35mm in 13 patients  (13%).
SIZE NO. OF PATIENTS
8 – 15mm 70
16 – 25mm 17
26 – 35mm 13
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STONE SIZE DISTRIBUTION
SIDE DISTRIBUTION
It  was observed that 65 patients had Right sided stones and 35 patients had Left sided 
stone. 
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LOCATION
Stone distribution anatomically was 58 patients had stone in renal pelvis, 25 patients had 
stone in upper calyx, 10 patients had stone in middle calyx and 7 patients had stone in 
lower Calyx with favourable anatomy.
LOCATION NO. OF PATIENTS
Pelvis 58
Upper Calyx 25
Middle Calyx 10
Lower Calyx 7
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STENTING 
Stone  Size  >25mm  were  stented,  30  pateints  were  stented  and  70  patients  were 
nonstented.
STENTING DONE STENTING NOT DONE
30 70
30
70
Stenting Done Stenting Not Done
STONE DENSITY IN CT SCAN
68 Patients had CT HU 320-750
12 patients had CT HU 750-1000
20 patients had > 1000 HU
STONE DENSITY IN HU
68
12
20
320-750 750-1000 >1000 HU
FRAGMENTATION AND CLEARANCE 
Out of 100 patients,  in 68 patients stone completely disappeared. 12 patients had 
good fragmentation and 20 patients had clinically significant residual fragment.
DESCRIPTION STONE FREE FRAGMENTED 
COMPLETELY
RESIDUAL 
FRAGMENTS
No. of Patients 68 12 20
Stone Density 320-750 750-1000 >1000
No. of Shocks 800-2200 2500-6000 5000-7500
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Stone Free Fragmented
Completely
Residual
Fragments
68  patients  had  stone  density  320-750.  I  sitting  ESWL  done  No.  of  Shocks 
800-2200. Stone completely disappeared.
Among the 68 patients 58 patients 8-15mm Size
16-25mm in 6 patients, 4 patients had 26mm – 35mm
Eventhough the size >2.5cm if HU is <750 
Stone fragmentation rate is good.
STONE FREE 
PATIENTS
68
58 6 4
Stone Size (Diameter) 8-15mm 16-25mm 26-35mm
Stone Density 320-750
No. of Shocks 800-2200
12 Patients  had stone  density  of  750-1000.  Among the 12 Patients  7  Patients 
underwent  II  sitting  ESWL and  stone  fragmented.  5  Patients  underwent,  III  Sitting 
ESWL and store completely fragmented. Among 12 Patients  6 Patients had stone size, 
8-15mm,  4 patients  had stone size 16-25mm and 2 patients had stone size 26-35mm. In 
the II Group Re-treatment is needed.
STONE 
FRAGMENTED 
COMPLETELY
12
6 4 2
Stone Size (Diameter) 8-15mm 16-25mm 26-35mm
Stone Density 750-1000
No. of Shocks 5000-6000
• 7  Patients  residual  fragments  at  2  weeks  and  underwent  II  Sitting 
ESWL.
• 5 Patients underwent III Sitting ESWL and became stone free.
20 Patients had stone density of > 1000 HU and received 7500 shocks, III Sitting 
ESWL  patients  had  clinically  significant  fragment  >4mm.  In  this  group  auxillary 
procedures PCNL, open surgery (or) URS is needed. 
STONE WITH 
RESIDUAL 
FRAGMENTS
20
6 7 7
Stone Size (Diameter) 8-15mm 16-25mm 26-35mm
Stone Density > 1000
No. of Shocks 7500
Among  20 patients 6 patients had stone size 8-15mm. Eventhough the stone size 
is smaller since the HU > 1000 stone was not fragmented. 7 patients had size 16-25mm 
7 patients had 26-35mm.
CTHU
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From the above study it is obvious that size of the stone will not be able to predict 
the number of shock waves (eventhough moderate correlation) but stone density in HU 
will be able to predict the number of shocks needed in a better quantitative way.
MEAN SD
Age 37.18 12.38
Size mm 15.54 6.88
CT -  HU 811.30 419.34
Number of Shocks 3206.50 2300.11
Karl pearson 
correlation coefficient
Interpretation
No. of shocks 
Vs CT  -  HU
r=0.54 P=0.001 CT  -  HU increases shocks also 
increases .
There is a moderate correlation 
between shocks and CT  -  HU
No. of shocks 
Vs size mm
r=0.36P=0.001 Size mm increases shocks also 
increases.
There is a fair correlation 
between shocks and size
CT – HU No. of patients
Mean 
shock
Std. 
Deviation
One way 
ANOVA
F-test
<750 68 1978.99 775.754
750 -1000 12 3690.91 1454.960
>1000 20 7175.00 1453.444
Total 100 3206.50 2300.106
F=199.8
P=0.001
significant
INTERPRETATION FOR R-VALUE
Pearson correlation coefficient is denoted by “r”
“r” always lies between -1  to  +1 
0.0 – 0.2    poor correlation
0.2 - 0.4    fair correlation
0.4 - 0.6    moderate correlation
0.6 – 0.8    substantial correlation
0.8 - 1.0     strong correlation
CHEMICAL  COMPOSITION
The chemical composition of post ESWL fragments was obtained in 80 patients 
by chemical dissolution method (qualitative analysis). The following table depicts the 
various chemical composition.
20 patients  were not able to retrieve their stones.
TYPE OF STONE NO. OF 
PATIENTS
HU
Mixed  Stones  (Calcium,  Oxalate,  Phosphate  & 
Uric Acid)
70 400-1600
Uric Acid 3 320-350
Struvite Stones 7 400-600
Uric  acid  stones  completely  disappeared  in  a  single  sitting  with  ESWL  (HU 
320-350). Struvite stones had HU 400-600, stone fragmented  and cleared completely. 
Mixed stones had  varying, HU between 400-1600. Stone fragmentation also varies. 
STONE COMPOSITION ANALYSIS BY QUALITATIVE 
CHEMICAL ANALYSIS
NO. OF PATIENTS
Mixed Type 70 
Pure Uric Acid Stones 3
Magnesium Ammonium Phosphate 7
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COMPLICATIONS OBSERVED
 
Hematuria Dysuria 50 Analgesics, adequate oral fluids, 
observation.
Subcapsular Hematoma 5 Conservative line of Management
Perinephric Hematoma 3 Conservative line of Management
Stent Migration 1 URS/Stent repositioning
Steinstrasse 4 URS/Pathological Lead fragment 
broken
NO MAJOR COMPLICATIONS
                        DISCUSSION
ESWL has revolutionized the treatment strategy of urolithiasis world wide and 
continues to be a major therapeutic modality for treating a  majority of upper urinary 
tract  stones.   It’s  non  invasive  nature  along  with  high  efficacy  has  resulted  in 
outstanding patient and surgeon acceptance.
ESWL is  the  preferred  modality  of  treatment  for  renal  stones  less  than  2cm. 
However stone free rate (SFR) after treatment have never been near 100% and has been 
in the range of 65-75% (In our study 80%). 
The  success  rate  of  ESWL  is  determined  by  factors  such  as  stone  size, 
composition, location, presence of obstructive changes and anatomical anomalies. Stone 
composition  is  one  hidden  factor  which  decides  the  fragility  of  calculus  and  its 
susceptibility to ESWL. The number of shocks required for fragmentation is related not 
only to the size  of  the stone but  also to  its  hardeness (or)  brittleness which largely 
depends on its chemical composition.
CT  being  an  easily  available  modality  of  investigation  and  because  of  its 
increased sensitivity to density differences, has been used to measure stone densities of 
various types of calculi and attempts are made to correlate the density with chemical 
composition.
Hillman reported   89% overall  accuracy  of  CT Scan  to  categorize  uric  acid, 
calcium oxalate and struvite calculi. On the contrary Kuwahara et al reported that there 
is no correlation between the attenuation value and the chemical composition of renal 
stone.  In  our  study we also could not  find  any correlation between CT density  and 
chemical  composition  of  stone.  The  predominant  stone  (Mixed  stone)  of  calcium 
oxalate, phosphate, uric acid had stone HU ranging from  400-1600 and the values were 
overlapped for various calculi.
Joseph et al reported overall success rate of 80% for calculus upto 2cm. When 
they assessed the susceptibility of stone fragmentation by ESWL according to HU, they 
found that the success rate for stone with attenuation value < 1000 HU was significantly 
higher than that for stone with value >1000 HU. In their study they found a significant 
correlation  between  number  of  shocks  required  for  stone  fragmentation  and  the 
attenuation value of the stone.
We  noted  that  80/100  patients  with  CT  density  of  less  than  1000  HU  had 
significantly successful treatment. 68 patients cleared their stone in the I sitting ESWL. 
7 patients pulverized their stone in II Sitting ESWL and 5 patients undergone III Sitting 
ESWL for complete clearance. 20 patients with CT HU >1000 HU had unsuccessful 
fragmentation even after  7500 shock waves.  Thus the CT density of the renal stone is 
inversely proportional to the fragmentation and clearance.
        
CT density  α = --------------------------------- 
     Fragmentation and Clearance
Patients with CT HU>1000 required more number of shock waves.
The success rate of ESWL is also related to chemical composition of stone. Uric 
acid and struvite stones having HU < 750 easily fragment. Mixed calcium oxalate and 
cystine stones are known to fragment with difficulty by ESWL. Though cystine stones 
have HU <1000, these stones are ESWL resistant because of their greater deformation 
capability and higher resistance to crack propagation. Ductile stones (Smooth cystine 
calculi) can absorb the energy of cavitation jet impact through plastic deformation thus 
preventing the cavitation damage  produced on the anterior surface of stone.
Size and Location of stones are the other variables depending on which success of 
ESWL fairly correlates. 
Narmata Gupta et al   in their study concluded that NCCT predict the treatment 
outcome of ESWL. So might help in planning alternative treatment in patients with a 
likelihood of poor outcome from ESWL. The calculus density was a stronger predictor 
of ESWL outcome than size of stone.
Joseph et al, in study of 30 patients, those with Calculi < 500 HU had complete 
clearance in 2500 shocks. Stones with 500-1000 HU had clearance rate of 86% and 
median number of shock waves 3390. Patients with calculi  > 1000 HU had clearance 
rate of 55% requiring a median of >3000 shock waves. 
Motley et al  concluded that there is no significant difference between density 
values of calcium oxalate and calcium phosphate calculus.
Pareek et al  correlated calculus density with clearance in 50 Patients. 36%  of 
patients had residual calculi with their mean density of  >  900 HU compared to 74% 
clearance with mean density of 500 HU.
100 patients with renal calculi measuring between 8mm – 35mm were included in 
our study. The stone density measured on NCCT and mean density value obtained. All 
patients were treated with ESWL and the susceptibility of renal stone to fragmentation 
was correlated with stone density and its chemical composition.
The overall success rate of ESWL was 80% in our study.
68/100 patients with <750 HU had 100% stone fragmentation and clearance.
12/100 patients with 750-1000 HU  had 59% stone fragmentation and clearance 
in  the  II  Sitting  and  41%  had  stone  fragmentation  and  clearance  in  III  Sitting. 
(Retreatment with ESWL needed). 
20/100 patients with HU > 1000 had significant residual fragment even after III 
sitting  ESWL  (Auxillary  Procedures  needed).  (There  was  a  statistically  significant 
difference with P<0.001).
Comparing stone size with ESWL fragility, eventhough stone size > 2.5cm, if the 
stone density is < 750 HU stone fragmentation is 100%.
Even  if  the  stone  size  <  15mm,  a  stone  density  of   >1000  HU shows  poor 
fragmentation with ESWL.
On  stone  composition  analysis,  uric  acid  and  struvite  stones  had  fragmented 
completely in the I  sitting.  The chemical  composition of mixed renal  stones did not 
correlate with attenuation value of stone.
CONCLUSION
For stones with HU < 750 and stone size even upto 3.5cm, stone free rate of 
100% can be achieved with ESWL.
For stones  with 750 – 1000 HU patient  may need  retreatment (Multiple 
Sittings ESWL).
For stones with HU >1000 other modalities  of  treatment (Endoscopic and 
Open Stone Surgery) are preferable to ESWL.
NON CONTRAST CT estimation of stone density by HOUNSFIELD UNIT 
predicts the successful outcome of ESWL therapy.
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MASTER CHART
S.N Name Age Sex Side Location Size mm
Stenting 
Done  / 
Not Done
CTH
U
Number of 
Shocks
Stone 
composition
Results
SELVARAJ 28 M R P 8 Not Done 720 2100 M SF -  I
GUNASEKARAN 32 M R UC 10 Not Done 750 3200 M SF -  II
SATHIYA 56 F R P 12 Not Done 1200 7500 X FAIL  - III
JEEVANATHAN 41 M L MC 9 Not Done 350 800 U SF -I
DHANDAPANI 27 M R P 28 Done 1100 7500 X FAIL - III
GANDHIPATHI 29 F R LC 11 Not Done 400 900 MAP SF -I
ANNADURAI 42 M R P 27 Done 1010 7500 X FAIL -III
SOMU 56 M L P 12 Not Done 650 2100 M SF -I
RAMNIVAS 55 M R MC 32 Done 1200 7500 X FAIL -III
10 SOFIYA 6 F L P 14 Not Done 400 900 M SF -I
11 RAMADURAI 27 M R UC 33 Done 1400 7500 X FAIL -III
12 RAVI 34 M L LC 12 Not Done 600 2000 M SF -I
13
RADHAKRISHNA
N 35 M R P 14 Not Done 600 2200 M SF -I
14 PALANIAMMAL 35 F L MC 34 Done 350 1200 U SF -I
15 BASKAR 32 M L P 12 Not Done 400 1200 M SF -I
16 RATHNAMMAL 40 F L LC 10 Not Done 500 1400 MAP SF -I
17 ARUMUGHAM 46 M R P 14 Not Done 1300 7500 X FAIL -III
18 RAMCHAND 42 F L UC 35 Done 400 1400 M SF -I
19 VIKNESH 5 M R P 12 Not Done 380 1000 M SF -I
20 GOPAL 24 M R P 15 Not Done 680 2000 M SF -I
21 MADHESH 22 M R P 12 Not Done 600 2200 M SF -I
S.N Name Age Sex Side Location Size mm
Stenting 
Done  / 
Not Done
CTH
U
Number of 
Shocks
Stone 
composition Results
BASKAR 28 M R UC 26 Done 1170 7500 X FAIL -III
NALINIAMMAL 42 F L P 14 Not Done 680 2100 M SF -I
BALARAMAN 25 M R MC 26 Done 1240 7500 X FAIL -III
NARIRAM 26 M L UC 13 Not Done 680 2100 M SF-I
SAVITHIRI 38 F R P 15 Not Done 1140 7500 X FAIL -III
PARAMASIVAN 42 M R LC 14 Not Done 710 2100 M SF-I
VENKATACHALA
M 48 M L P 13 Not Done 720 2200 M SF-I
DEEPA 23 F R UC 10 Not Done 740 2200 M SF-I
GURUMOORTHY 52 M R MC 10 Not Done 690 2000 M SF-I
MALA 40 F L P 14 Not Done 700 2100 M SF-I
SELVAPERUMAL 56 M R UC 12 Not Done 600 2000 MAP SF-I
LAKSHMANAN 60 M R LC 10 Not Done 1250 7500 X FAIL -III
INBAJOTHI 27 F R P 8 Not Done 620 2000 M SF-I
RANI 6 M L UC 9 Not Done 630 2000 M SF-I
MANGALRAM 40 M R MC 10 Not Done 640 2000 M SF-I
PARVATHI 24 F R P 27 Done 1600 7500 X FAIL –III
MAHABUNISHA 52 F L LC 12 Not Done 710 2200 M SF-I
SATHISH KUMAR 33 M R P 13 Not Done 740 2200 M SF –I
BASKAR 35 M R P 30 Not Done 760 2800 M SF-II
MOORTHY 32 M R UC 10 Done 610 2100 M SF-I
SURESH 34 M R UC 12 Not Done 620 2200 M SF-I
SELVI 23 F L P 13 Not Done 730 2200 M SF-I
KANNAN 26 M R MC 24 Done 950 6000 M SF-II
KUMAR 28 M R P 15 Not Done 740 2200 M SF-I
S.N Name Age Sex Side Location Size mm
Stenting 
Done  / 
Not Done
CTH
U
Number of 
Shocks
Stone 
composition Results
46 LOGANATHAN 42 M L P 10 Not Done 480 7500 X FAIL –III
47 BHUVANESWARI 32 F R MC 9 Not Done 600 2000 M SF-I
48 GURUMOORTHY 40 M R P 32 Done 700 1800 M SF-I
49 HAMEED 20 M L UC 14 Not Done 750 2200 M SF-I
50 HAMAVATHY 41 F R P 9 Not Done 730 2100 M SF-I
51 SATHISH KUMAR 28 M R UC 10 Not Done 740 2100 M SF-I
52 LALITHA 57 F L MC 33 Done 500 1600 MAP SF-I
53 LOGANATHAN 32 M R P 10 Not Done 450 1600 MAP SF-I
54 DEVARAJAN 33 M R UC 13 Not Done 800 2800 M SF -II
55 DHANALAKSHMI 38 F L P 16 Done 320 850 U SF-I
56 KADAR BABU 52 m R LC 14 Not Done 400 1200 MAP SF-I
57 PALANI 55 M L P 25 Done 400 1100 M SF-I
58 VEERAPERUMAL 56 M R UC 15 Not Done 1500 7500 X FAIL -III
59 GAJALAKSHMI 42 F L UC 24 Done 550 1800 M SF-I
60 VENKATESAN 57 M R P 18 Done 600 2000 M SF-I
61 SUKUMAR 52 M R P 8 Not Done 620 2100 M SF-I
62 KRISHNAN 48 M R UC 19 Done 620 2200 M SF-I
63 RANI 32 F L P 9 Not Done 710 2100 M SF-I
64 RAMESH 22 M R UC 20 Done 750 3200 M SF -II
65 MURUGAN 30 M R P 22 Done 780 2800 M SF -II
66 KUMAR 38 F L P 12 Not Done 850 3400 M SF -II
67 SELVARAJ 32 M R UC 10 Not Done 730 2200 M SF-I
68 KASI 36 M L MC 24 Done 800 3000 M SF -II
69 GOMATHI 28 F R P 11 Not Done 400 1400 MAP SF-I
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70 SIVARAJA 42 M R UC 25 Done 900 3500
71
SANDANAKRISHNA
N 45 M L P 14 Not Done 620 1800
72 PURUSOTHAMAN 47 M L UC 12 Not Done 900 6000
73 JAYAKUMARI 27 F R P 17 Done 990 5800
74 MATHIMOHAN 58 M R P 13 Not Done 640 1900
75 MUNUSAMY 56 M R UC 18 Done 1100 7500
76 JEEVA 46 F L P 12 Not Done 650 1900
77 MURUGESAN 24 M L P 17 Done 1200 7500
78 NAGARAJ 30 M R P 16 Done 1300 7500
79 AMUDHA 27 F R P 11 Not Done 710 2000
80 SOUNDAR 20 M R P 10 Not Done 690 1900
81 DURAI RAJ 42 M R P 8 Not Done 640 1900
82 RAJAGOPAL 40 M L P 10 Not Done 650 1800
83 MOBANA 24 F R P 12 Not Done 720 2100
84 DHANADAPANI 38 M R UC 22 Done 1450 7500
85 ANANDHAN 56 M L P 14 Not Done 740 2200
86 ALAMELU 32 F R UC 15 Not Done 750 2200
87 VELAYUTHAM 58 M L P 23 Done 1600 7500
88 ELUMALAI 55 M L UC 10 Not Done 500 1500 MAP
89 TAMARAJ KANI 48 F R P 24 Done 1500 7500
90 ARUMUGHAM 35 M R UC 10 Not Done 700 2000
91 MOORTHY 37 M L P 18 Done 1280 7500
92 KARPAGAVALI 57 F L P 12 Not Done 740 2200
93 SIVARAMAN 42 M L P 11 Not Done 950 5600
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94 SUBRAMANIYAN 41 M R P 14 Not Done 690 1900 M
95 SARAVANAN 38 M R P 15 Not Done 720 2100 M
96 CHINNAPILLAI 50 F R P 14 Not Done 710 2200 M
97 PARASURAMAN 36 M R P 10 Not Done 1000 6000 M
98 GEETHA 22 F R P 12 Not Done 740 2100 M
99 VENKATESAN 28 M R P 10 Not Done 740 2200 M
100 SATHISH KUMAR 20 M R P 12 Not Done 700 2000 M
COMPARISON BETWEEN STONE HU AND 
STONE BREAKAGE RATE
S.No
Name Age / Sex I.P.No
Address
Symptoms Duration
Clinical Examinations
Investigations :
Urine culture & Sensitivity
RFT
Basic Metabolic Workup
X –Ray                   Site     Size          Side             No. of Stones
USG KUB                              PCS Dilation                                        Y/N
                                               Stone Located
IVU
CT :           Plain HU
ESWL Details
Premedication :        Y/N
IV sedation :        Y/N
Medication (Tamsulosin) :        Y/N
Stone Localization by :        Fluro / USG
Total No. of shocks :
Frequency :
Intensity :
Stenting done :        Y/N
Rpt procedure done :        Y/N
Stone Fragmentation Rate :
Stone Composition :
Follow -up
PATIENT CONSENT FORM
Study Title :  “THE ROLE OF NON CONTRAST CT-KUB IN 
PREDICTING THE STONE FRAGILITY AND ESWL SUCCESS RATE”
Study Centre : Department of Urology
Patient’s Name :
Patient’s Age :
Identification No :
Patients may tick these Boxes [  ]
I confirm that I have understood the purpose of procedure for the above study. [  ]
I have the opportunity to ask the questions and all my questions and doubts [  ]
have been answered to my complete satisfaction.
I understand that my participation in the study is voluntary and that I am [  ]
free to withdraw at any time without giving any reason, without my legal
right being affected
I understand that sponsor of the clinical study, others working on the
sponsor’s behalf, the ethics committee and the regulatory authorities will
not need my permission to look at my health records both in respect of the [  ]
current study and any further research that may be conducted in relation
to it, even if I withdraw from study.
I agree to this access, however, I understand that my identity would not be [  ]
revealed. In any information released to third parties or published, unless as
required under the law.
I agree not to restrict the use of any data or results that arise from this study. [  ]
I agree to take part in the above study and to comply with the instructions
given during the study and to faithfully to cooperate with the study team, [  ]
and to immediately inform the study staff if I suffer from any deterioration
in my health or my well being or any unexpected or unusual symptoms.
I hereby give consent to participate in this study. [  ]
 
Signature / Thumb Impression .....................................................................................
of the patient:
Place : .........................................................................................
Patient’s name and address : .........................................................................................
Signature of the Investigator :.................................Place ......................Date ...............
Name of the Investigator : .............................................................................................

